Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Natalia Delis"'
Autor:
Vida Vafaizadeh, Bernd Groner, Boris Brill, Natalia Delis, Richard Moriggl, Corina Borghouts, Christian Brendel, Axel Weber
Publikováno v:
Pharmaceuticals, Vol 6, Iss 8, Pp 960-987 (2013)
The signal transducer and activator of transcription Stat5 is transiently activated by growth factor and cytokine signals in normal cells, but its persistent activation has been observed in a wide range of human tumors. Aberrant Stat5 activity was in
Externí odkaz:
https://doaj.org/article/90b771fd216f485f8c85940a24bd80e8
Autor:
Natalia Delis, Corina Borghouts, Christian Brendel, Richard Moriggl, Bernd Groner, Vida Vafaizadeh, Boris Brill, Axel Weber
Publikováno v:
Cancers, Vol 7, Iss 1, Pp 503-537 (2015)
Cancers
Volume 7
Issue 1
Pages 503-537
Cancers
Volume 7
Issue 1
Pages 503-537
Signal transducers and activators of transcription (Stats) play central roles in the conversion of extracellular signals, e.g., cytokines, hormones and growth factors, into tissue and cell type specific gene expression patterns. In normal cells, thei
Publikováno v:
Analytical Biochemistry. 466:83-88
The presence of endotoxins in preparations of recombinantly produced therapeutic proteins poses serious problems for patients. Endotoxins can cause fever, respiratory distress syndromes, intravascular coagulation, or endotoxic shock. A number of meth
Autor:
Diane Richter, Chul Min Yang, Viktoria von Manstein, Vida Vafaizadeh, Bernd Groner, Natalia Delis
Publikováno v:
Current Signal Transduction Therapy
Scopus-Elsevier
Scopus-Elsevier
The emergence of low molecular weight kinase inhibitors as "targeted" drugs has led to remarkable advances in the treatment of cancer patients. The clinical benefits of these tumor therapies, however, vary widely in patient populations and with durat
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 138:1205-1220
Background Proteins involved in the aberrant regulation of signaling pathways and their downstream effectors are promising targets for cancer therapy. Survivin is an antiapoptotic and cell cycle-promoting protein, which is consistently overexpressed
Autor:
Boris Brill, Laura Mack, Corina Borghouts, Natalia Delis, Peter Lucks, Astrid Weiss, Bernd Groner
Publikováno v:
JAK-STAT
Cancer cells are characterized by the aberrant activation of signaling pathways governing proliferation, survival, angiogenesis, migration and immune evasion. These processes are partially regulated by the transcription factor STAT3. This factor is i
Autor:
Corina Borghouts, Bernd Groner, Boris Brill, Hannah Schöneberger, Astrid Weiss, Natalia Delis
Publikováno v:
Hormone Molecular Biology and Clinical Investigation. 5:1-9
We are characterizing peptides which are able to interact with functional domains of oncoproteins and thus inhibit their activity. The yeast two-hybrid system was used to derive a peptide sequence which specifically interacts with the dimerization do
Publikováno v:
Molecular Cancer Research. 6:267-281
Signal transduction events often involve the assembly of protein complexes dependent on modular interactions. The inappropriate assembly of modular components plays a role in oncogenic transformation and can be exploited for therapeutic purposes. Sel
Autor:
Tomohiro Chiba, Boris Brill, Viktoria von Manstein, Vida Vafaizadeh, Thomas Oellerich, Natalia Delis, Bernd Groner, Chul Min Yang
Publikováno v:
International Journal of Cancer
Cellular transformation is initiated by the activation of oncogenes and a closely associated developmental reprogramming of the epigenetic landscape. Transcription factors, regulators of chromatin states and microRNAs influence cell fates in developm
Autor:
Corina Borghouts, Bernd Groner, Boris Brill, Christian Brendel, Vida Vafaizadeh, Axel Weber, Natalia Delis, Richard Moriggl
Publikováno v:
Pharmaceuticals
Volume 6
Issue 8
Pages 960-987
Pharmaceuticals, Vol 6, Iss 8, Pp 960-987 (2013)
Volume 6
Issue 8
Pages 960-987
Pharmaceuticals, Vol 6, Iss 8, Pp 960-987 (2013)
The signal transducer and activator of transcription Stat5 is transiently activated by growth factor and cytokine signals in normal cells, but its persistent activation has been observed in a wide range of human tumors. Aberrant Stat5 activity was in